|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2004-2-3
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
N
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/4-hydroxyanisole,
http://linkedlifedata.com/resource/pubmed/chemical/Anisoles,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Antioxidants,
http://linkedlifedata.com/resource/pubmed/chemical/Antiprotozoal Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Iduronidase,
http://linkedlifedata.com/resource/pubmed/chemical/Indoles,
http://linkedlifedata.com/resource/pubmed/chemical/Isoenzymes,
http://linkedlifedata.com/resource/pubmed/chemical/Propylamines,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrrolidines,
http://linkedlifedata.com/resource/pubmed/chemical/Quinazolines,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin Receptor Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/Thiazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Tryptamines,
http://linkedlifedata.com/resource/pubmed/chemical/adalimumab,
http://linkedlifedata.com/resource/pubmed/chemical/agalsidase beta,
http://linkedlifedata.com/resource/pubmed/chemical/alefacept,
http://linkedlifedata.com/resource/pubmed/chemical/alpha-Galactosidase,
http://linkedlifedata.com/resource/pubmed/chemical/atomoxetine,
http://linkedlifedata.com/resource/pubmed/chemical/eletriptan,
http://linkedlifedata.com/resource/pubmed/chemical/gefitinib,
http://linkedlifedata.com/resource/pubmed/chemical/nitazoxanide
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0360-4039
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
34
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
56-62; quiz 63-4
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:14758333-Anisoles,
pubmed-meshheading:14758333-Antibodies, Monoclonal,
pubmed-meshheading:14758333-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:14758333-Antineoplastic Agents,
pubmed-meshheading:14758333-Antioxidants,
pubmed-meshheading:14758333-Antiprotozoal Agents,
pubmed-meshheading:14758333-Antirheumatic Agents,
pubmed-meshheading:14758333-Attention Deficit Disorder with Hyperactivity,
pubmed-meshheading:14758333-Drug Approval,
pubmed-meshheading:14758333-Drug Therapy,
pubmed-meshheading:14758333-Fabry Disease,
pubmed-meshheading:14758333-Humans,
pubmed-meshheading:14758333-Iduronidase,
pubmed-meshheading:14758333-Indoles,
pubmed-meshheading:14758333-Isoenzymes,
pubmed-meshheading:14758333-Lentigo,
pubmed-meshheading:14758333-Lung Neoplasms,
pubmed-meshheading:14758333-Migraine Disorders,
pubmed-meshheading:14758333-Mucopolysaccharidosis I,
pubmed-meshheading:14758333-Patient Education as Topic,
pubmed-meshheading:14758333-Propylamines,
pubmed-meshheading:14758333-Psoriasis,
pubmed-meshheading:14758333-Pyrrolidines,
pubmed-meshheading:14758333-Quinazolines,
pubmed-meshheading:14758333-Recombinant Fusion Proteins,
pubmed-meshheading:14758333-Serotonin Receptor Agonists,
pubmed-meshheading:14758333-Thiazoles,
pubmed-meshheading:14758333-Tryptamines,
pubmed-meshheading:14758333-alpha-Galactosidase
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
New drugs 04, part 1.
|
|
pubmed:publicationType |
Journal Article
|
